Mannkind Corp

NASDAQ:MNKD 4:00:00 PM EDT

6.34

-0.15 (-2.31%)

: $6.31 -0.03 (-0.47%)

Market Cap (Intraday)	1.74B
Current PE	148.53
Forward PE	70.44
2yr Forward PE	35.22

See more stats

Estimates Current Quarter

Revenue	$72.2 Million
Adjusted EPS	$0.03

See more estimates

10-Day MA	$6.36
50-Day MA	$5.88
200-Day MA	$4.77

See more pivots

Mannkind Corp Stock, NASDAQ:MNKD

1 Casper Street, Suite 300, Danbury, Connecticut 06810

United States of America

Phone: +1.818.661.5000

Number of Employees: 414

http://www.mannkindcorp.com

Description

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.